CANCER IMMUNOLOGY IMMUNOTHERAPY是一本专注于癌症免疫学和免疫治疗领域的国际期刊，ISSN号为0340-7004，由德国出版商Springer出版，出版地为德国，出版周期为月刊。该期刊的影响因子较高，具体数值需根据最新JCR报告确认，属于SCI收录期刊，并根据中科院分区标准通常位于医学或免疫学领域的较高分区。期刊并非完全开放获取（OA），但提供部分OA选项。其发文特点集中于癌症免疫机制、免疫治疗策略、肿瘤微环境、免疫检查点抑制剂、疫苗开发及临床试验等研究方向，旨在推动癌症免疫治疗的基础与临床转化研究。期刊质量较高，审稿严格，但投稿竞争激烈，可能存在发表周期较长或拒稿率较高的风险，适合高水平研究成果投稿。
Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies
2024-01-17T12:02:16Z
Rescue of NLRC5 expression restores antigen processing machinery in head and neck cancer cells lacking functional STAT1 and p53
2024-01-17T12:02:16Z
Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastases
2024-01-17T12:02:16Z
Phellinus linteus activates Treg cells via FAK to promote M2 macrophage polarization in hepatocellular carcinoma
2024-01-19T11:01:48Z
Human colorectal cancer: upregulation of the adaptor protein Rai in TILs leads to cell dysfunction by sustaining GSK-3 activation and PD-1 expression
2024-01-04T10:02:37Z
Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study
2024-01-04T11:01:56Z
Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment
2024-01-18T12:01:32Z
CD204-positive M2-like tumor-associated macrophages increase migration of gastric cancer cells by upregulating miR-210 to reduce NTN4 expression
2024-01-04T10:02:37Z
HDAC6 inhibitor ACY-1215 enhances STAT1 acetylation to block PD-L1 for colorectal cancer immunotherapy
2024-01-17T12:02:16Z
Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8+ clonal effector and CAR T-cell function while promoting a senescence-associated phenotype
2024-01-17T12:02:16Z
Targeted therapies in retinoblastoma: GD2-directed immunotherapy following autologous stem cell transplantation and evaluation of alternative target B7-H3
2024-01-19T11:01:48Z
Predictive value of peripheral blood biomarkers in patients with non-small-cell lung cancer responding to anti-PD-1-based treatment
2024-01-17T12:02:16Z
Leukocyte-associated immunoglobulin-like receptor-1 blockade in combination with programmed death-ligand 1 targeting therapy mediates increased tumour control in mice
2024-01-18T11:43:09Z
Vaccination against neoantigens induced in cross-priming cDC1 in vivo
2024-01-17T12:02:16Z
PD-L1-positive circulating endothelial progenitor cells associated with immune response to PD-1 blockade in patients with head and neck squamous cell carcinoma
2024-01-04T11:01:56Z
Protective effect of low‐intensity pulsed ultrasound on immune checkpoint inhibitor-related myocarditis via fine-tuning CD4+ T-cell differentiation
2024-01-18T06:01:49Z
Coordination of anti-CTLA-4 with whole-brain radiation therapy decreases tumor burden during treatment in a novel syngeneic model of lung cancer brain metastasis
2024-01-19T11:01:48Z
Oncolytic adenovirus coding for shedding-resistant MICA enhances immune responses against tumors
2024-01-05T10:02:27Z
